These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 31043277)

  • 21. The Clinical Significance of Endometrial Cells Detected on Pap Testing: The Impact of Revisions to the 3rd Edition of the Bethesda System for Reporting Cervical Cytology.
    Morikawa LH; Tauchi-Nishi PS
    Ann Clin Lab Sci; 2017 May; 47(3):298-305. PubMed ID: 28667030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Asymptomatic thickened endometrium in postmenopausal women: malignancy risk.
    Famuyide AO; Breitkopf DM; Hopkins MR; Laughlin-Tommaso SK
    J Minim Invasive Gynecol; 2014; 21(5):782-6. PubMed ID: 24632398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A single institution experience with the new bethesda system for reporting thyroid cytopathology: correlation with existing cytologic, clinical, and histological data.
    McElroy MK; Mahooti S; Hasteh F
    Diagn Cytopathol; 2014 Jul; 42(7):564-9. PubMed ID: 24431292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytologically benign endometrial cells in the papanicolaou smears of postmenopausal women.
    Chang A; Sandweiss L; Bose S
    Gynecol Oncol; 2001 Jan; 80(1):37-43. PubMed ID: 11136567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In Papanicolaou smears, benign appearing endometrial cells bear no significance in predicting uterine endometrial adenocarcinomas.
    Moatamed NA; Le LT; Levin MR; Govind R; Apple SK
    Diagn Cytopathol; 2013 Apr; 41(4):335-41. PubMed ID: 22102567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequency of Adequate Endometrial Biopsy in Evaluation of Postmenopausal Women With Benign Endometrial Cells on Pap Test.
    Hastings JW; Alston MJ; Mazzoni SE; Stickrath E
    J Low Genit Tract Dis; 2017 Oct; 21(4):258-260. PubMed ID: 28953115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Classification of benign endometrial glandular cells in cervical smears from postmenopausal women.
    Brogi E; Tambouret R; Bell DA
    Cancer; 2002 Apr; 96(2):60-6. PubMed ID: 11954022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of tamoxifen on endometrial histology, hormone receptors, and cervical cytology: a prospective study with follow-up.
    Leslie KK; Walter SA; Torkko K; Stephens JK; Thompson C; Singh M
    Appl Immunohistochem Mol Morphol; 2007 Sep; 15(3):284-93. PubMed ID: 17721273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histological Pattern Of Endometrial Samples In Postmenopausal Women With Abnormal Uterine Bleeding.
    Deeba F; Shaista ; Khan B
    J Ayub Med Coll Abbottabad; 2016; 28(4):721-724. PubMed ID: 28586596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance of reporting benign-appearing endometrial cells in Pap tests in women aged 40 years and over.
    Jones E; Frain BM; Crabtree W
    Acta Cytol; 2009; 53(1):18-23. PubMed ID: 19248550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of benign endometrial cells in Pap smears from postmenopausal women.
    Wu HH; Schuetz MJ; Cramer H
    J Reprod Med; 2001 Sep; 46(9):795-8. PubMed ID: 11584479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Five-year follow-up of patients with recurrent postmenopausal bleeding.
    Twu NF; Chen SS
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Aug; 63(8):628-33. PubMed ID: 10969449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the benefit and use of the new terminology in endometrial cytology reporting system.
    Shinagawa A; Kurokawa T; Yamamoto M; Onuma T; Tsuyoshi H; Chino Y; Iwasaki K; Mori M; Imamura Y; Yoshio Y
    Diagn Cytopathol; 2018 Apr; 46(4):314-319. PubMed ID: 29460481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tamoxifen and endometrial pathologies: a prospective study.
    Seoud M; Shamseddine A; Khalil A; Salem Z; Saghir N; Bikhazi K; Bitar N; Azar G; Kaspar H
    Gynecol Oncol; 1999 Oct; 75(1):15-9. PubMed ID: 10502419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance of endometrial cells in cervical cytology.
    Yu EJ; Park NH; Song YS; Lee YK
    J Obstet Gynaecol; 2016 Oct; 36(7):966-969. PubMed ID: 27560859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of endometrial hyperplasia without atypia in peri- and postmenopausal women with a levonorgestrel intrauterine device.
    Haimovich S; Checa MA; Mancebo G; Fusté P; Carreras R
    Menopause; 2008; 15(5):1002-4. PubMed ID: 18451744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy: follow up study.
    Wells M; Sturdee DW; Barlow DH; Ulrich LG; O'Brien K; Campbell MJ; Vessey MP; Bragg AJ
    BMJ; 2002 Aug; 325(7358):239. PubMed ID: 12153918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term clinical outcomes following resectoscopic endometrial ablation of non-atypical endometrial hyperplasia in women with abnormal uterine bleeding.
    Vilos GA; Oraif A; Vilos AG; Ettler H; Edris F; Abu-Rafea B
    J Minim Invasive Gynecol; 2015 Jan; 22(1):66-77. PubMed ID: 25048567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liquid-based endometrial cytology: its possible value in postmenopausal asymptomatic women.
    Buccoliero AM; Castiglione F; Gheri CF; Garbini F; Fambrini M; Bargelli G; Pappalardo S; Scarselli G; Marchionni M; Taddei GL
    Int J Gynecol Cancer; 2007; 17(1):182-7. PubMed ID: 17291251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of implementing The Bethesda System for reporting of thyroid FNA at an academic center.
    Theoharis C; Adeniran AJ; Roman S; Sosa JA; Chhieng D
    Diagn Cytopathol; 2013 Oct; 41(10):858-63. PubMed ID: 23512999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.